Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -0.07%3.84B | 9.70%2.84B | -5.25%1.28B | -36.62%4.95B | -35.76%3.85B | -35.47%2.59B | 8.92%1.35B | -37.90%7.81B | -27.75%5.99B | -32.11%4.01B |
| Refunds of taxes and levies | 37.21%51.78M | -15.85%12.56M | 647.92%2.04M | -67.50%83.32M | -84.18%37.74M | -89.90%14.92M | -99.77%273.34K | 27.90%256.42M | 39.93%238.54M | 11.48%147.8M |
| Cash received relating to other operating activities | -39.70%93.07M | -60.47%51.2M | -47.96%29.99M | -13.21%196.17M | -10.68%154.36M | 15.02%129.51M | -13.83%57.62M | 14.30%226.04M | 68.46%172.82M | 42.96%112.59M |
| Cash inflows from operating activities | -1.24%3.99B | 6.24%2.91B | -6.88%1.31B | -36.93%5.23B | -36.89%4.04B | -36.02%2.73B | -1.22%1.41B | -36.09%8.29B | -25.25%6.4B | -30.20%4.27B |
| Goods services cash paid | 17.91%2.25B | 21.07%1.56B | 17.59%910.19M | -15.61%2.5B | -25.04%1.91B | -26.44%1.29B | -22.32%774.04M | -44.71%2.96B | -30.62%2.54B | -4.47%1.75B |
| Staff behalf paid | 8.60%760.71M | 5.12%517.01M | 11.71%305.77M | 7.04%923.13M | 12.75%700.47M | 15.72%491.84M | 40.90%273.71M | 24.35%862.41M | 30.88%621.24M | 32.45%425.04M |
| All taxes paid | -40.88%251.77M | -53.97%152.56M | -61.74%85.44M | -63.54%534.84M | -65.96%425.86M | -67.42%331.44M | -61.32%223.33M | -26.54%1.47B | -20.46%1.25B | -13.46%1.02B |
| Cash paid relating to other operating activities | -9.40%324.13M | 3.01%264.02M | 15.41%130.16M | -46.30%390.97M | -36.77%357.76M | -38.48%256.31M | -22.05%112.78M | -4.74%728.01M | 12.09%565.84M | 14.16%416.6M |
| Cash outflows from operating activities | 5.73%3.59B | 5.31%2.5B | 3.45%1.43B | -27.75%4.35B | -31.93%3.39B | -34.40%2.37B | -27.65%1.38B | -31.70%6.02B | -19.89%4.98B | -2.28%3.61B |
| Net cash flows from operating activities | -37.71%403.36M | 12.26%409.14M | -656.58%-122.38M | -61.24%881.54M | -54.31%647.51M | -44.88%364.46M | 104.49%21.99M | -45.38%2.27B | -39.50%1.42B | -72.75%661.19M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 488.67%2.46B | 363.43%574.98M | 129.88%105.48M | -41.57%486.07M | 92.17%417.89M | -42.94%124.07M | -8.23%45.89M | 459.48%831.95M | --217.45M | --217.45M |
| Cash received from returns on investments | 737.59%110.57M | 492.12%65.31M | --18.73M | 123.55%13.26M | 367.30%13.2M | 610.00%11.03M | ---- | 19.18%5.93M | --2.82M | --1.55M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --0 | ---- | ---- | 2.01%2.14M | 2.18%2.14M | -86.50%78.95K | -88.52%33.54K | -95.21%2.09M | 9,406.29%2.09M | 2,558.03%584.77K |
| Net cash received from disposal of subsidiaries and other business units | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | --50.1M | --50.1M | --14.76K | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 504.91%2.62B | 410.72%690.39M | 170.53%124.23M | -40.30%501.47M | 94.82%433.23M | -38.44%135.18M | -8.69%45.92M | 325.40%839.97M | 106.13%222.37M | 256.83%219.59M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -21.93%492.49M | -22.25%362.84M | -28.65%225.69M | -75.13%771.51M | -76.74%630.86M | -77.58%466.7M | -69.57%316.32M | -15.72%3.1B | 11.03%2.71B | 47.60%2.08B |
| Cash paid to acquire investments | 314.48%2.92B | 125.11%1.16B | 55.10%331.6M | -47.71%740M | -24.49%703.8M | -33.70%513.8M | 113.80%213.8M | -11.43%1.42B | 213.79%932.08M | 215.54%775M |
| Net cash paid to acquire subsidiaries and other business units | --15.84M | ---- | ---- | ---- | --0 | ---- | ---- | 759.17%214.79M | 219.16%214.79M | 357.01%214.79M |
| Cash paid relating to other investing activities | -94.16%141.74K | -96.82%76.46K | -98.42%13.41K | --718.9K | --2.42M | --2.41M | -99.48%846.75K | ---- | --0 | ---- |
| Cash outflows from investing activities | 156.19%3.43B | 54.60%1.52B | 4.96%557.31M | -68.05%1.51B | -65.35%1.34B | -68.00%982.9M | -64.98%530.97M | -10.78%4.73B | 37.33%3.86B | 37.99%3.07B |
| Net cash flows from investing activities | 10.95%-804.88M | 2.19%-829.13M | 10.71%-433.08M | 74.03%-1.01B | 75.14%-903.86M | 70.27%-847.72M | 66.91%-485.04M | 23.78%-3.89B | -34.59%-3.64B | -31.77%-2.85B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 1,261.25%61.26M | --59.76M | --59.76M | 96.66%4.5M | 350.00%4.5M | ---- | ---- | -97.87%2.29M | -99.97%1M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --1.5M | ---- | ---- | 96.66%4.5M | --0 | ---- | ---- | 128.82%2.29M | ---- | ---- |
| Cash from borrowing | 30.11%1.52B | 2.97%1.19B | -64.60%350.47M | 30.58%2.49B | -12.79%1.17B | 0.89%1.16B | 17.64%989.91M | 3.75%1.91B | 22.32%1.34B | 57.48%1.15B |
| Cash received relating to other financing activities | --0 | ---- | --394.15M | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 34.83%1.59B | 8.14%1.25B | -18.74%804.38M | 30.66%2.49B | -12.52%1.18B | 0.89%1.16B | 17.64%989.91M | -64.92%1.91B | -72.06%1.34B | 20.95%1.15B |
| Borrowing repayment | 17.84%1.05B | -19.72%656.92M | -51.84%247.56M | 73.20%2.09B | 86.20%893.85M | 88.99%818.29M | 121.02%514.06M | 27.29%1.21B | -16.03%480.04M | -18.15%432.98M |
| Dividend interest payment | -58.86%264.52M | -63.55%221.81M | -8.70%17.94M | -46.28%672.61M | -47.64%642.96M | -48.18%608.49M | 57.21%19.64M | 143.30%1.25B | 144.35%1.23B | 137.68%1.17B |
| -Including:Cash payments for dividends or profit to minority shareholders | --3.14M | --740K | ---- | ---- | --0 | ---- | ---- | --30M | ---- | ---- |
| Cash payments relating to other financing activities | 73.07%248.08M | 72.28%246.95M | --245.19M | 10.60%262.25M | -12.37%143.35M | 64.05%143.35M | ---- | -54.91%237.13M | -57.70%163.57M | -77.40%87.38M |
| Cash outflows from financing activities | -6.80%1.57B | -28.31%1.13B | -4.31%510.69M | 12.18%3.02B | -10.22%1.68B | -7.35%1.57B | 39.57%533.71M | 35.58%2.69B | 28.10%1.87B | 20.21%1.69B |
| Net cash flows from financing activities | 103.84%19.37M | 130.27%125.16M | -35.62%293.68M | 32.63%-530.27M | 4.38%-504.37M | 24.57%-413.43M | -0.63%456.2M | -122.81%-787.06M | -115.75%-527.47M | -18.68%-548.12M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -61.83%-8.2M | -414.96%-3.75M | -763.99%-3.23M | 35.94%5.23M | -181.63%-5.07M | -86.85%1.19M | 92.64%-373.3K | -65.28%3.85M | -52.09%6.21M | 94.95%9.05M |
| Net increase in cash and cash equivalents | 49.03%-390.35M | 66.66%-298.58M | -3,566.33%-265M | 72.76%-654.26M | 72.05%-765.79M | 67.19%-895.51M | 99.52%-7.23M | -195.33%-2.4B | -191.23%-2.74B | -1,301.28%-2.73B |
| Add:Begin period cash and cash equivalents | -29.00%1.6B | -29.00%1.6B | -29.99%1.6B | -51.56%2.26B | -51.56%2.26B | -51.56%2.26B | -50.88%2.29B | 117.80%4.66B | 117.80%4.66B | 117.80%4.66B |
| End period cash equivalent | -18.71%1.21B | -4.21%1.3B | -41.38%1.34B | -29.00%1.6B | -22.27%1.49B | -29.44%1.36B | -27.74%2.28B | -51.56%2.26B | -62.71%1.92B | -0.80%1.93B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.